Apertura Gene Therapy and Rett Syndrome Research Trust
NEW YORK and TRUMBULL, Conn., April 30, 2025 (GLOBE NEWSWIRE) -- Apertura Gene Therapy, a biotechnology company focused on innovative...
Rett
Apertura Gene Therapy and Rett Syndrome Research Trust Collaborate to Pioneer Advanced Genetic Medicines for Rett Syndrome Using TfR1-Targeted AAV Capsid
NEW YORK and TRUMBULL, Conn., April 30, 2025 /PRNewswire/ -- Apertura Gene Therapy, a biotechnology company focused on innovative gene therapy...
